| Literature DB >> 30003388 |
Chengyan Chu1,2, Yue Gao3, Xiaoyan Lan1, Aline Thomas2, Shen Li4.
Abstract
The neural cell adhesion molecule (NCAM) plays a pivotal role in the development and maintenance of the nervous system via homophilic (NCAM-NCAM) and heterophilic (NCAM-other molecules) interactions. Many synthetic peptides have been engineered to mimic these interactions and induce NCAM-downstream signaling pathways. Such NCAM mimetics have displayed neuritogenic and neuroprotective properties, as well as synaptic modulation in vitro and in vivo. Furthermore, they have been used successfully in preclinical studies to treat neurological disorders including stroke, traumatic brain injury and Alzheimer's disease. This review focuses on recent progress in the development of NCAM mimetic peptides, in particular, on establishing C3, plannexin, and FGL as therapeutic candidates for neurological disorders.Entities:
Keywords: Bioactive peptides; Fibroblast growth factor receptor; Mimetic peptides; Neural cell adhesion molecule; Neurological disorders
Mesh:
Substances:
Year: 2018 PMID: 30003388 DOI: 10.1007/s11064-018-2594-8
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996